In less than three months, the federal government is set to announce the initial 10 drugs subject to first-ever price negotiations in Medicare.Pharmaceutical companies and their supporters want to stop that from happening.Last week, Merck and the US Chamber of Commerce filed separate lawsuits against the government, arguing that negotiating drug prices in Medicare is unconstitutional in a variety of ways.
[
add
]
[
|
|
...
]